IE
MRVI icon

Israel Englander’s Maravai LifeSciences MRVI Stock Holding History

Israel Englander’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.6M Buy
6,508,220
+4,858,730
+295% +$21M 0.01% 1030
2026
Q1 		$4.67M Sell
1,649,490
-147,562
-8% -$500K ﹤0.01% 3021
2025
Q4 		$5.84M Buy
1,797,052
+1,357,349
+309% +$4.57M ﹤0.01% 2840
2025
Q3 		$1.26M Buy
439,703
+191,616
+77% +$489K ﹤0.01% 4440
2025
Q2 		$598K Sell
248,087
-1,128,634
-82% -$2.37M ﹤0.01% 4780
2025
Q1 		$3.04M Sell
1,376,721
-530,540
-28% -$2.1M ﹤0.01% 3377
2024
Q4 		$10.4M Sell
1,907,261
-2,418,051
-56% -$15.6M 0.01% 2142
2024
Q3 		$35.9M Sell
4,325,312
-1,643,280
-28% -$14.2M 0.02% 1058
2024
Q2 		$42.7M Buy
5,968,592
+713,639
+14% +$6.16M 0.02% 907
2024
Q1 		$45.6M Sell
5,254,953
-531,896
-9% -$3.6M 0.02% 883
2023
Q4 		$37.9M Buy
5,786,849
+1,524,650
+36% +$9.85M 0.02% 998
2023
Q3 		$42.6M Buy
4,262,199
+4,040,786
+1,825% +$44.4M 0.02% 814
2023
Q2 		$2.75M Buy
221,413
+211,020
+2,030% +$2.85M ﹤0.01% 3201
2023
Q1 		$146K Sell
10,393
-2,585,155
-100% -$37.1M ﹤0.01% 5290
2022
Q4 		$37.1M Buy
2,595,548
+799,274
+44% +$12.6M 0.02% 959
2022
Q3 		$45.9M Buy
1,796,274
+1,687,021
+1,544% +$42.3M 0.03% 727
2022
Q2 		$3.1M Sell
109,253
-555,426
-84% -$17.6M ﹤0.01% 3263
2022
Q1 		$23.4M Buy
664,679
+143,060
+27% +$4.8M 0.01% 1227
2021
Q4 		$21.9M Buy
521,619
+142,869
+38% +$5.79M 0.01% 1353
2021
Q3 		$18.6M Buy
378,750
+100
+0% +$4.88K 0.01% 1400
2021
Q2 		$15.8M Buy
378,650
+13,045
+4% +$506K 0.01% 1430
2021
Q1 		$13M Sell
365,605
-340,093
-48% -$11.3M 0.01% 1509
2020
Q4 		$19.8M Buy
+705,698
New +$19.7M 0.01% 1080

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Israel Englander's MRVI Position: Q2 2026 in Review

Israel Englander increased its Maravai LifeSciences (MRVI) stake by 295% in Q2 2026, buying an estimated $21M and bringing the position to 6,508,220 shares worth $40.6M. The position accounts for 0.01% of the portfolio, ranked #1030.

Israel Englander first reported a position in MRVI in Q4 2020 and has held it in 23 quarters since. The position peaked at $45.9M in Q3 2022. 177 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Israel Englander held 6,508,220 shares of Maravai LifeSciences worth $40.6M as of Q2 2026.
  • Israel Englander bought 4,858,730 Maravai LifeSciences shares in Q2 2026, an estimated $21M.
  • Maravai LifeSciences made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1030 holding.
  • Israel Englander first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 23 quarters since.
  • Israel Englander's Maravai LifeSciences position peaked at $45.9M in Q3 2022.
  • 177 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.